RemedyRepack Inc. recalls Glimepiride 2 mg tablets, packaged in a) 30-count bottles (NDC 70518-0405-03), b) 90-count bottles (NDC 70518-0405-00) a
Recalled April 12, 2023 · FDA recall D-0493-2023 · RemedyRepack
Hazard
cGMP Deviations · FDA Class II
Units
a) 147 bottles, b)70 bottles, c) 3 bottles
Sold at
RemedyRepack distributed product to consignees nationwide within the United States
Description
cGMP Deviations
Product
Glimepiride 2 mg tablets, packaged in a) 30-count bottles (NDC 70518-0405-03), b) 90-count bottles (NDC 70518-0405-00) and c)180-count bottles (NDC 70518-0405-02), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701
Manufacturer(s)
RemedyRepack Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →